Pilots that praise you, then quietly never convert to paid. The problem usually isn't the product — it's that the pilot was never designed to close.
Anatolie Clevan · Founder, LeadsACE · Updated June 11, 2026It's the most common story in healthtech: the pilot goes live, the staff likes it, the champion says glowing things on the check-in call — and then nothing. No contract. No rejection either. Just a deal that ages in the CRM until everyone stops asking. The praise was real. It just wasn't evidence, and it was never attached to a decision.
"See how it goes" is not a metric. Before the pilot starts, both sides agree on the number that defines success — calls answered, hours saved, bookings recovered — and the threshold that triggers the next conversation. If you can't name the number, you're running a free trial, not a pilot.
The person who can sign a contract must know the pilot exists, know the success threshold, and agree — in advance — that hitting it means a purchase decision. A pilot whose results report only to the champion produces enthusiasm, not revenue.
The pilot agreement itself states what happens on success: pricing, term, start date. Not binding the buyer to purchase — binding both sides to a decision. The deals that drift are the ones where converting was always meant to be "a conversation for later."
The pilot's job is to produce the CFO's slide. That means measurement starts before go-live: baseline the current state (answer rate, no-shows, hours spent), track the delta weekly, and translate it into dollars in the buyer's own units. When the pilot ends, the question "did it work?" should already be answered by a chart — not by asking the staff how they felt about it.
Charge for pilots when you can. Even a nominal fee changes the psychology on both sides: paid pilots get implemented, measured, and discussed at budget level; free ones get treated like a demo that overstayed. If strategy demands free — a flagship logo, a new specialty — then keep every other structure (metric, buyer, clause) twice as tight, because you've removed the one that costs them something.
Don't wait for the end. The midpoint check-in is where conversion is actually decided: results so far against the agreed metric, what's on track, and — explicitly — "if we finish at this level, are we proceeding per the agreement?" Surfacing a hidden veto at week three is recoverable. Discovering it after the pilot ends is a postmortem.
This structure is how Voxira signed 12 clinics (~$160K ARR) while the product was still being finished — the pilots weren't demos running on hope; they were sales instruments with a defined finish line.
One excited clinician is not a deal. The playbook for the other 6–10 people.
The real cost math on your first sales hire — from someone who's been both.
What unanswered phones and slow follow-up actually cost a practice per year.
Usually for structural reasons, not product ones: no pre-agreed success metric, no named economic buyer who sees the results, and no conversion clause. Without those, a pilot is a free trial with no path to 'yes.'
Three structures set before it starts: a pre-agreed success metric (not 'see how it goes'), named roles including the economic buyer, and a conversion clause stating pricing, term, and start date on success.
Either can work, but a free pilot with no conversion clause and no economic buyer attached is the one that stalls. A small paid commitment signals intent and forces the buyer to assign budget and an owner.
A success metric, named roles (champion, day-to-day owner, economic buyer), and a conversion clause — what happens on success: pricing, term, and start date. The pilot exists to produce the CFO's slide.